Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] - N0000175823
Pharmacologic Class Information
Pharmacologic Code | N0000175823 |
Pharmacologic Name | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme
The table contains 4 products whose active ingredient are classified under the same pharmacologic class Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
54092-700 | Elaprase | Non-Proprietary Name: Idursulfase | Solution, Concentrate | Intravenous | Takeda Pharmaceuticals America, Inc. | ACTIVE | |
58468-0070 | Aldurazyme | Non-Proprietary Name: Laronidase | Injection, Solution, Concentrate | Intravenous | Genzyme Corporation | ACTIVE | |
68135-020 | Non-Proprietary Name: Galsulfase | Solution | Biomarin Pharmaceutical Inc. | ACTIVE | |||
68135-020 | Naglazyme | Non-Proprietary Name: Galsulfase | Solution | Intravenous | Biomarin Pharmaceutical Inc. | ACTIVE | |
68135-100 | Non-Proprietary Name: Elosulfase Alfa | Injection, Solution, Concentrate | Biomarin Pharmaceutical Inc. | ACTIVE | |||
68135-100 | Vimizim | Non-Proprietary Name: Elosulfase Alfa | Injection, Solution, Concentrate | Intravenous | Biomarin Pharmaceutical Inc. | ACTIVE |